Clinical Trial Detail


Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at :

NCT ID NCT02116777
Title BMN-673 and Temozolomide in Treating Younger Patients With Refractory or Recurrent Malignancies
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors National Cancer Institute (NCI)

lymphoid leukemia

Advanced Solid Tumor

Ewing sarcoma


Talazoparib + Temozolomide

Age Groups: adult | child
Covered Countries USA

No variant requirements are available.